← FDA DRUG APPROVALS

FDA ANDA · ANDA076851

LEVOCARNITINE

Sponsor: RISING

APPLICATION
ANDA076851
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-10
LATEST ACTION
2004-08-10
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

LEVOCARNITINEPrescription
LEVOCARNITINE 1GM/10ML · SOLUTION · ORAL

Approval history

2004-08-10OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →